Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
10:00am, Monday, 05'th Jun 2023
Teva is refocusing its efforts on biosimilar medicines and cost-cutting. It's also looking to broaden its pipeline more generally to develop more generics.
5 Very Well Known Buy-Rated Stocks Under $10 Could Explode Higher This Summer
06:10am, Saturday, 27'th May 2023
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
3 Generic Drug Stocks to Watch Amid Macro Headwinds
09:08am, Tuesday, 23'rd May 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that four studies across its
Teva Will Slim Down Its Generic Drug Business
12:20pm, Thursday, 18'th May 2023
The new corporate strategy aims to deliver a “pivot to growth," the drugmaker said.
Why Teva Pharmaceutical Stock Is Jumping Today
11:59am, Thursday, 18'th May 2023
Teva announced a new growth strategy. This news sparked an upgrade of the pharma stock by one analyst.
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today?
10:37am, Thursday, 18'th May 2023
Teva Pharmaceuticals (NYSE: TEVA ) stock is climbing higher on Thursday after the pharmaceutical company announced a new growth strategy. Teva Pharmaceuticals has laid out the four pillars of how it p
Teva Pharmaceutical announces new growth strategy built on biosimilars, innovation
09:05am, Thursday, 18'th May 2023
Teva Pharmaceutical Industries on Thursday launched a new “pivot to growth” strategy, based on existing growth drivers like Austedo and Ajovy as well as generics, further innovation, and focused c
Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat Sales
09:15am, Wednesday, 10'th May 2023
Teva Pharmaceutical reported lighter-than-expected earnings for the first quarter, leading Teva stock to plunge early Wednesday. The post Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat S
Teva Pharmaceutical Is Stabilizing Hinting A Payoff Potential
09:59pm, Tuesday, 25'th Apr 2023
Teva Pharmaceutical Is Stabilizing Hinting A Payoff Potential.
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
12:00pm, Tuesday, 18'th Apr 2023
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
08:56am, Saturday, 15'th Apr 2023
In theory, the stock of companies that make generic drugs have the potential to be safe investments. Despite that, companies like Teva Pharmaceuticals aren't actually safe at all.
Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023
04:15pm, Friday, 14'th Apr 2023
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first quarter 2023 financial results on Wednesday
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
11:26am, Friday, 14'th Apr 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
08:00am, Wednesday, 05'th Apr 2023
Millions of people are scrambling to navigate the Adderall shortage in a saga closely watched by investors in Teva and other drug stocks. Here's what you should know.
